T-CELL LYMPHOMA

Clinical trials for T-CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new T-CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 1 Completed 4 Terminated 2

New drug combo aims to shrink Hard-to-Treat lymphoma

Disease control Terminated

This early-stage trial tests whether combining two drugs, azacitidine and abatacept, can shrink tumors in adults with T-cell lymphoma that has come back or not responded to prior therapy. About 20 participants will receive the drugs in 28-day cycles for up to 13 cycles. The study…

Matched conditions: T-CELL LYMPHOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 05, 2026 12:05 UTC

T-CELL LYMPHOMA

Get alerted when new T-CELL LYMPHOMA trials appear

New drug combo aims to shrink Hard-to-Treat lymphoma